Literature DB >> 18677531

Endovascular treatment of a superior mesenteric artery aneurysm secondary to Behcet's disease with Onyx (ethylene vinyl alcohol copolymer).

Koray Güven1, Izzet Rozanes, Murat Kayabali, Ozenç Minareci.   

Abstract

Behcet's disease is a complex multisystemic chronic inflammatory disease that is characterized by oral and genital aphtous ulcers and vasculitis. Aneurysms of major arteries are the most important cause of mortality in Behcet's disease. Four patients with superior mesenteric artery (SMA) aneurysms related to Behcet's disease have been reported in the literature. We report here the first successful endovascular treatment of a giant, wide-necked SMA aneurysm secondary to Behcet's disease. We performed a balloon-assisted embolization technique using ethylene vinyl alcohol copolymer (Onyx, ev3, Irvine, CA, USA). There were no signs of recurrence during 2-year follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677531     DOI: 10.1007/s00270-008-9403-8

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Embolization of traumatic and non-traumatic peripheral vascular lesions with Onyx.

Authors:  Renato Regine; Francesco Palmieri; Michele De Siero; Antonio Rescigno; Vincenzo Sica; Raffaele Cantarela; Vincenzo Villari
Journal:  Interv Med Appl Sci       Date:  2015-03-20

2.  Presentation and management of rare saccular superior mesenteric artery trunk and branch aneurysms.

Authors:  Sunny Sahajwani; Besher Tolaymat; Ali Khalifeh; Motahar Hosseini; Rafael Santini-Dominguez; David Blitzer; Rajabrata Sarkar; Shahab Toursavadkohi
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-07-19

Review 3.  Spontaneous Intra-Abdominal Hemorrhage Due to Rupture of Jejunal Artery Aneurysm in Behcet Disease: Case Report and Literature Review.

Authors:  Xiao-Yan Wu; Jiang-Peng Wei; Xiu-Yuan Zhao; Yue Wang; Huan-Huan Wu; Tao Shi; Tong Liu; Gang Liu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.